pregabalin
Generic: pregabalin
Labeler: aphena pharma solutions - tennessee, llcDrug Facts
Product Profile
Brand Name
pregabalin
Generic Name
pregabalin
Labeler
aphena pharma solutions - tennessee, llc
Dosage Form
CAPSULE
Routes
Active Ingredients
pregabalin 150 mg/1
Manufacturer
Identifiers & Regulatory
Product NDC
71610-618
Product ID
71610-618_d2de5bd4-13ac-4b83-8fa2-a75513e408fc
Product Type
HUMAN PRESCRIPTION DRUG
Marketing Category
ANDA
Application Number
ANDA208677
DEA Schedule
cv
Listing Expiration
2026-12-31
Marketing Start
2019-07-19
Normalized Code Variants
Searchable formats for this product NDC code
Digits Only
71610618
Hyphenated Format
71610-618
Supplemental Identifiers
RxCUI
UNII
Resolved Product View
Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.
Resolved Identity
Brand Name
pregabalin (source: ndc)
Generic Name
pregabalin (source: ndc)
Application Number
ANDA208677 (source: ndc)
Routes
source: ndc
Resolved Composition
Strengths
- 150 mg/1
Packaging
- 30 CAPSULE in 1 BOTTLE (71610-618-30)
- 56 CAPSULE in 1 BOTTLE (71610-618-46)
- 60 CAPSULE in 1 BOTTLE (71610-618-53)
- 84 CAPSULE in 1 BOTTLE (71610-618-54)
- 120 CAPSULE in 1 BOTTLE (71610-618-70)
Packages (5)
Ingredients (1)
Linked Drug Pages (1)
Raw FDA Data
View complete raw FDA NDC JSON payload
{"route": ["ORAL"], "spl_id": "d2de5bd4-13ac-4b83-8fa2-a75513e408fc", "openfda": {"unii": ["55JG375S6M"], "rxcui": ["483440", "483448"], "spl_set_id": ["aa55a53c-96f6-4e0a-8b1d-e9d36e6ef2ec"], "manufacturer_name": ["Aphena Pharma Solutions - Tennessee, LLC"]}, "finished": true, "packaging": [{"sample": false, "description": "30 CAPSULE in 1 BOTTLE (71610-618-30)", "package_ndc": "71610-618-30", "marketing_start_date": "20220531"}, {"sample": false, "description": "56 CAPSULE in 1 BOTTLE (71610-618-46)", "package_ndc": "71610-618-46", "marketing_start_date": "20220531"}, {"sample": false, "description": "60 CAPSULE in 1 BOTTLE (71610-618-53)", "package_ndc": "71610-618-53", "marketing_start_date": "20211202"}, {"sample": false, "description": "84 CAPSULE in 1 BOTTLE (71610-618-54)", "package_ndc": "71610-618-54", "marketing_start_date": "20240716"}, {"sample": false, "description": "120 CAPSULE in 1 BOTTLE (71610-618-70)", "package_ndc": "71610-618-70", "marketing_start_date": "20220531"}], "brand_name": "Pregabalin", "product_id": "71610-618_d2de5bd4-13ac-4b83-8fa2-a75513e408fc", "dosage_form": "CAPSULE", "product_ndc": "71610-618", "dea_schedule": "CV", "generic_name": "PREGABALIN", "labeler_name": "Aphena Pharma Solutions - Tennessee, LLC", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Pregabalin", "active_ingredients": [{"name": "PREGABALIN", "strength": "150 mg/1"}], "application_number": "ANDA208677", "marketing_category": "ANDA", "marketing_start_date": "20190719", "listing_expiration_date": "20261231"}